Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017;7(2):168-182.
doi: 10.1007/s40140-017-0210-0. Epub 2017 Apr 12.

Extracorporeal Life Support: Four Decades and Counting

Omar S Alibrahim  1 , Christopher M B Heard  2
Affiliations
Review

Extracorporeal Life Support: Four Decades and Counting

Omar S Alibrahim et al. Curr Anesthesiol Rep. 2017.

Abstract

Extracorporeal membrane oxygenation (ECMO) or extracorporeal life support (ECLS) is a form of heart lung bypass that is used to support neonates, pediatrics, and adult patients with cardiorespiratory failure for days or weeks till organ recovery or transplantation. Venoarterial (VA) and venovenous (VV) ECLS are the most common modes of support. ECLS circuit components and monitoring have been evolving over the last 40 years. The technology is safer, simpler, and more durable with fewer complications. The use of neonatal respiratory ECLS use has been declining over the last two decades, while adult respiratory ECLS is growing especially since the H1N1 influenza pandemic in 2009. This review provides an overview of ECLS evolution over the last four decades, its use in neonatal, pediatric and adults, description of basic principles, circuit components, complications, and outcomes as well as a quick look into the future.

Keywords: ARDS; Cardiac ECLS; Congenital diaphragmatic hernia; Double lumen cannula; ECLS; ECMO; Extracorporeal life support; Extracorporeal membrane oxygenation; Internal jugular vein; Respiratory failure; Venoarterial; Venovenous.

PubMed Disclaimer

Conflict of interest statement

Conflict of InterestOmar Al-Ibrahim and Christopher M.B. Heard declare they have no conflict of interest.

References

    1. •• Rais-Bahrami K, Van Meurs KP, et al. Venoarterial versus venovenous ECMO for neonatal respiratory failure. Semin Perinatol. 2014;38(2):71–77. WB Saunders. Neonatal ECMO has resulted in significant improvement the survival of neonates with cardiorespiratory failure unresponsive to conventional therapy with encouraging long term outcomes. - PubMed
    1. Bartlett RH, Gazzaniga AB, Jefferies MR, Huxtable RF, Haiduc NJ, Fong SW, et al. Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. ASAIO J. 1976;22(1):80–92. - PubMed
    1. Bartlett RH, Andrews AF, Toomasian JM, Haiduc NJ, Gazzaniga AB, et al. Extracorporeal membrane oxygenation for newborn respiratory failure: forty-five cases. Surgery. 1982;92(2):425–433. - PubMed
    1. Gray BW, Haft JW, Hirsch JC, Annich GM, Hirschl RB, Bartlett RH, et al. Extracorporeal life support: experience with 2000 patients. ASAIO journal (American Society for Artificial Internal Organs: 1992) 2015;61(1):2. - PMC - PubMed
    1. Dalton HJ, et al. Extracorporeal life support: moving at the speed of light. Respiratory Care September. 2011;56(9):1445–1456. doi: 10.4187/respcare.01369. - DOI - PubMed

LinkOut - more resources